Due to an error in data coding, tables 1-3 are replaced by the following. The Corrigendum Note below each table explains the error and correction.
NPV, Negative predictive value: probability of (−) laboratory drug tests and (−) self-rated assessments; PPV, positive predictive value: probability of (+) laboratory drug tests and (+) self-rated assessments; SENS, sensitivity: proportion of (+) laboratory drug tests and (+) self-rated assessments; SPEC, specificity: proportion of (−) laboratory drug tests and (−) self-rated assessments; 'Any use' indicates the use of cocaine, cannabis or methamphetamine; laboratory drug test (+/−) includes urine drug test results and radioimmunoassay (RIA) of hair test results.
Corrigendum Note. As indicated in this updated version of Table 2 , a greater proportion of women under-reported drug use as compared to men, but this finding is now a trend and is not significant at conventional thresholds. The other findings that are reported in this version of Table 2 are not qualitatively different than the results that were previously reported in error. Corrigendum Note. Compared to the results that were previously reported, the findings reported in this updated version of Table 3 suggest that positive symptomatology is a significant predictor of the under-reporting of cannabis use. The updated results also indicate that age is a significant predictor of the under-reporting of cocaine use. There are no other qualitative differences of mention between this version of Table 3 and the results that were previously reported in error.
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